Figure 1From: A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]Schematic of the study protocol. There was a randomized assignment to Group I or II. During the washout periods, treatment was limited to the daily use of a compressive garment, with manual lymphatic drainage or other intervention. The vertical arrows indicate the times at which volumetry was performed by circumferential measurements of the limbs. The SF-36 was administered before and after each of the 14 day treatment phases.Back to article page